General Nurse Practitioner News

NP

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mease PJ et al. - The findings support a positive risk/benefit profile for duloxetine in the long-term treatment of fibromyalgia.

Related Articles

Changes in Hippocampal Metabolites After Effective Treatment for Fibromyalgia: A Case Study
The Clinical Journal of Pain, 10/20/09    Relevance Score: 94%

Womens narratives on experiences of work ability and functioning in fibromyalgia
Musculoskeletal Care, 10/23/09    Relevance Score: 93%

General symptom reporting in female fibromyalgia patients and referents: a population-based case-referent study
BMC Public Health, 11/04/09    Relevance Score: 90%

Fibromyalgia: From treatment to rehabilitation
European Journal of Pain, 11/17/09    Relevance Score: 89%

Are chronic fatigue syndrome and fibromyalgia the same? Implications for the provision of appropriate mental health intervention
Journal of Psychiatric and Mental Health Nursing, 11/16/09    Relevance Score: 89%

Today in Clinical Pharmacology...keeping you current

Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/18/09

Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/18/09

New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09